Manuel A. Santiago, MD
Hematology & Oncology Physician · San Antonio, TX
Manuel A. Santiago, MD is a hematology & oncology physician with a practice address in San Antonio, Texas, and NPI 1760454458, issued on Feb 6, 2006. Check the license (Texas J7651, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.
- Name
- Manuel A. Santiago
- Credential
- MD
- Primary taxonomy
- Hematology & Oncology Physician 207RH0003X
- License number
- J7651 TX
Self-reported in NPPES; status is on the state search - Practice location
- 5206 Research Dr, San Antonio, TX 78240
- Phone
- (210) 595-5300
- Enumerated
- Feb 6, 2006
- Record last updated
- Feb 26, 2018 (not updated in 8 years: call before relying on the address or phone)
- Fax
- (210) 614-8740
- Medicaid IDs
- 126541501 TX
126541506 TX
126541507 TX - Medicare enrollment
- Enrolled (PECOS I20100329000656); accepts Medicare assignment
- Medical or professional school
- University Of Puerto Rico School Of Medicine, 1986
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
Also registered at 5206 Research Dr
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Hycienth Ahaneku, MDHematology & Oncology Physician1811346695
- Emmalind Aponte, MDHematology & Oncology Physician1699985002
- Lokesh Bathla, MDTransplant Surgery Physician1053537290
- Sridhar Beeram, MDHematology & Oncology Physician1275626970
- Vinnette Bullock-Price, FNPFamily Nurse Practitioner1154336626
- M Canty, CNSClinical Nurse Specialist1477898088
Verify Manuel A. Santiago in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersTexas Medical Board
Search for license J7651Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
34% more Medicare Part D claims than the average hematology & oncology physician in 2024
1,172 Medicare Part D claims for 196 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 27% of claims. 111 claims were for opioids.
Most prescribed
- Anastrozole78 claims
- Hydrocodone-Acetaminophen66 claims
- Eliquis64 claims
- Xarelto64 claims
- Letrozole45 claims
- Revlimid45 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The MIPS final score for 2023 (Medicare payment program): 89.4 of 100
The Merit-based Incentive Payment System score is reported for this clinician. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023; category weights for 2023 (qpp.cms.gov).
Industry payments in 2024: $147.26
3 payments; by number, the most common kind was food and beverage; the largest payer was E.R. Squibb & Sons, L.L.C. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Texas Oncology PASan Antonio, TX
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Hematology & Oncology Physician providers in Texas
There are 922 hematology & oncology physician records in Texas.
Other hematology & oncology physician records in Texas
- Kanza Abbas, M.D.Houston, TX1396065934
- Elham Abbasi-Hafshejani, M.D.The Woodlands, TX1306856513
- Raghad Abdul-Karim, MDMcAllen, TX1114207172
- Seyed Abedi, M.D.,PH.D.Cedar Park, TX1033567409
- Muhammad Abid, M.D.Lubbock, TX1639480437
- Ambrose Aboud, MDEl Paso, TX1407843873
- Hesham Abowali, MDGalveston, TX1447806955
- Joel Abramowitz, M.D., PHDHouston, TX1447220413
- Hussna Abunafeesa, M.DDallas, TX1902338726
- Prashanth Adapala, M.D.Marble Falls, TX1740484336
Common questions
What is Manuel A. Santiago, MD's NPI number?
Manuel A. Santiago, MD's National Provider Identifier (NPI) is 1760454458, issued on Feb 6, 2006. An NPI identifies a provider in billing; it is not a license.
Where is Manuel A. Santiago, MD located?
The NPPES record lists a practice address at 5206 Research Dr, San Antonio, TX, 78240. Phone: (210) 595-5300. Providers update this record themselves, so call before visiting.
How can I verify Manuel A. Santiago, MD's license?
NPPES lists Texas license number J7651, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Manuel A. Santiago, MD prescribe under Medicare Part D?
In 2024, Manuel A. Santiago, MD had 1,172 Medicare Part D claims for 196 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.
What is Manuel A. Santiago, MD's MIPS final score?
The 2023 MIPS final score is 89.4 of 100. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.